HON CORP(08259.HK)委任惠連旺及袁春洋為代表
格隆匯 10 月 14日丨HON CORP(08259.HK)公告,內容有關於中華人民共和國就"大健康"業務展開潛在合作。
為促進討論,公司謹此委任惠連旺及袁春洋為其代表。惠為一間於中國專門從事皮膚及組織細胞再生藥物的公司河北邁巴克集團有限公司的總裁。袁為一間於中國專門從事燻蒸養生產品的公司廣東蒸妙控股集團有限公司的總裁。由於惠及袁於"大健康"行業經驗豐富,公司已委任彼等為公司於討論中的代表。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.